Literature DB >> 20375886

Adrenal insufficiency: etiology, diagnosis and treatment.

Nicola Neary1, Lynnette Nieman.   

Abstract

PURPOSE OF REVIEW: Adrenal insufficiency, first codified in 1855 by Thomas Addison, remains relevant in 2010 because of its lethal nature. RECENT
FINDINGS: Reports illuminate features of adrenal insufficiency cause, diagnosis and treatment, and the role of glucocorticoids in critical illness.
SUMMARY: Progress has been made in identifying human leukocyte antigen and major histocompatability complex alleles that predispose to the development of adrenal insufficiency in patients with antibodies to 21-hydroxylase, but their role in clinical care is not established. Reports of HIV-associated infections and medication-induced hypocortisolism are reminders that autoimmune adrenal destruction does not underlie all cases. The diagnosis is adequately established by the 250 microg adrenocortocotropin hormone stimulation test in most patients; the 1 microg test carries the risk of misdiagnosis of healthy individuals as adrenally insufficient. Glucocorticoids provide life-saving treatment, but long-term quality of life is impaired, perhaps because therapy is not given in a physiologic way. The current recommended total daily dose is lower than that often prescribed. Dehydroepiandrosterone replacement may be useful in pubertal girls with hypopituitarism, but not in adults. Supraphysiologic hydrocortisone doses may aid in the reversal of septic shock independent of underlying adrenal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375886      PMCID: PMC2928659          DOI: 10.1097/MED.0b013e328338f608

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  60 in total

1.  Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy.

Authors:  A Verrips; M A Willemsen; E Rubio-Gozalbo; J De Jong; J A Smeitink
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

2.  Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.

Authors:  Edwin P Rock; Vicki Goodman; Janet X Jiang; Kooros Mahjoob; S Leigh Verbois; David Morse; Ramzi Dagher; Robert Justice; Richard Pazdur
Journal:  Oncologist       Date:  2007-01

3.  Reliability of the low dose synacthen test in children undergoing pituitary function testing.

Authors:  T Mushtaq; F Shakur; J K Wales; N P Wright
Journal:  J Pediatr Endocrinol Metab       Date:  2008-12       Impact factor: 1.634

4.  Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH).

Authors:  P F Speckart; J T Nicoloff; J E Bethune
Journal:  Arch Intern Med       Date:  1971-11

5.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects.

Authors:  E D Weitzman; D Fukushima; C Nogeire; H Roffwarg; T F Gallagher; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

6.  The apparent free cortisol concentration and the free cortisol index: a comparative study.

Authors:  T G Brien; A Clerico; M G Del Chicca; G C Zucchelli
Journal:  J Nucl Med Allied Sci       Date:  1981 Jan-Jun

7.  Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.

Authors:  Maro R I Williams; Tye Dawood; Shanhong Ling; Aozhi Dai; Robert Lew; Kathy Myles; John W Funder; Krishnankutty Sudhir; Paul A Komesaroff
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

8.  Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.

Authors:  Patricia Jabre; Xavier Combes; Frederic Lapostolle; Mohamed Dhaouadi; Agnes Ricard-Hibon; Benoit Vivien; Lionel Bertrand; Alexandra Beltramini; Pascale Gamand; Stephane Albizzati; Deborah Perdrizet; Gaelle Lebail; Charlotte Chollet-Xemard; Virginie Maxime; Christian Brun-Buisson; Jean-Yves Lefrant; Pierre-Edouard Bollaert; Bruno Megarbane; Jean-Damien Ricard; Nadia Anguel; Eric Vicaut; Frederic Adnet
Journal:  Lancet       Date:  2009-07-01       Impact factor: 79.321

9.  Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.

Authors:  Sam P L Rice; Neera Agarwal; Hemanth Bolusani; Robert Newcombe; Maurice F Scanlon; Marian Ludgate; D Aled Rees
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  28 in total

1.  [Malignant rheumatoid arthritis].

Authors:  M Nakahara
Journal:  Hokkaido Igaku Zasshi       Date:  1975-05

Review 2.  Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status.

Authors:  Yu-Cheng Huang; Yu-Lian Tang; Xiao-Ming Zhang; Nan-Lin Zeng; Rui Li; Tian-Wu Chen
Journal:  World J Radiol       Date:  2015-10-28

Review 3.  Diagnosis and management of pediatric adrenal insufficiency.

Authors:  Ahmet Uçar; Firdevs Baş; Nurçin Saka
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

4.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 5.  Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.

Authors:  Elisa González-Rodríguez; Delvys Rodríguez-Abreu
Journal:  Oncologist       Date:  2016-06-15

Review 6.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 7.  Corticosteroids for severe influenza pneumonia: A critical appraisal.

Authors:  Wagner Luis Nedel; David Garcia Nora; Jorge Ibrain Figueira Salluh; Thiago Lisboa; Pedro Póvoa
Journal:  World J Crit Care Med       Date:  2016-02-04

8.  Adrenal crisis presented as acute onset of hypercalcemia and hyponatremia triggered by acute pyelonephritis in a patient with partial hypopituitarism and pre-dialysis chronic kidney disease.

Authors:  Shunsuke Yamada; Hokuto Arase; Toshifumi Morishita; Akihiro Tsuchimoto; Kumiko Torisu; Takehiro Torisu; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2018-11-19

9.  Lesson of the month 2: Houssay phenomenon - hypopitutarism leading to remission of diabetes.

Authors:  Subhodip Pramanik; Rana Bhattacharjee; Pradip Mukhopadhyay; Sujoy Ghosh
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

10.  Anorexia nervosa: a mistaken diagnosis.

Authors:  Katie Nicholls; Nicola Boggis; Nikila Pandya
Journal:  BMJ Case Rep       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.